• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

    586.21 +6.32 (+1.09%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 4, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 219,571
    Open 582.59
    Bid (Size) 577.30 (40)
    Ask (Size) 595.50 (40)
    Prev. Close 579.89
    Today's Range 573.00 - 594.27
    52wk Range 265.00 - 605.00
    Shares Outstanding 17,103,395
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
    One fast-rising biotech is gearing up for pivotal trials just as a major specialist fund walks away—here’s what long-term investors should take from that divergence. 
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
    A brutal 90% single-day crash and a shareholder’s full exit raise the stakes for MoonLake’s upcoming FDA meeting. 
    Via The Motley Fool
    Topics Lawsuit Regulatory Compliance

    Performance

    YTD
    +86.8%
    +86.8%
    1 Month
    +42.2%
    +42.2%
    3 Month
    +34.7%
    +34.7%
    6 Month
    +109.9%
    +109.9%
    1 Year
    +82.4%
    +82.4%

    More News

    Read More
    News headline image
    Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
    Via The Motley Fool
    Topics Lawsuit Regulatory Compliance
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
    Via The Motley Fool
    Topics Initial Public Offering Regulatory Compliance
    News headline image
    Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum ↗
    Via Stocktwits
    News headline image
    Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Via Benzinga
    News headline image
    Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗
    Via Benzinga
    News headline image
    Madrigal Pharmaceuticals (NASDAQ:MDGL) Q3 2025 Earnings: Revenue Beat and EPS Miss Drive Pre-Market Surge ↗
    Via Chartmill
    News headline image
    A Look Ahead: Madrigal Pharmaceuticals's Earnings Forecast ↗
    Via Benzinga
    News headline image
    Beyond The Numbers: 10 Analysts Discuss Madrigal Pharmaceuticals Stock ↗
    Via Benzinga
    News headline image
    6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner ↗
    Via Benzinga
    News headline image
    A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 7 Analysts ↗
    Via Benzinga
    News headline image
    MADRIGAL PHARMACEUTICALS INC (NASDAQ:MDGL) Screens as High-Growth Momentum Stock Meeting Minervini Trend Template ↗
    Via Chartmill
    News headline image
    MarketBeat Week in Review – 09/08 - 09/12 ↗
    Via MarketBeat
    Topics Economy
    News headline image
    General Motors To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Friday ↗
    Via Benzinga
    News headline image
    A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 6 Analysts ↗
    Via Benzinga
    News headline image
    CoreWeave and Madrigal's Insider Trades Flash Bullish Signals ↗
    Via MarketBeat
    Topics Artificial Intelligence
    News headline image
    Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure ↗
    Via Investor's Business Daily
    News headline image
    Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker ↗
    Via Benzinga
    News headline image
    Madrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) ↗
    Via Benzinga
    News headline image
    Corporate Wins: Intel, Palo Alto Networks, and Novo Nordisk Drive Market Optimism
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Novo Nordisk Pops On A New Wegovy Approval, Dragging Hard On Madrigal Pharma ↗
    Via Investor's Business Daily
    News headline image
    Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease ↗
    Via Benzinga

    Frequently Asked Questions

    Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?
    Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market
    What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?
    The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 586.21
    When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 12/04/25 04:00 PM ET
    What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 10.03B
    How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?
    Madrigal Pharmaceuticals, Inc. - Common Stock has 10B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.